In Korea, 34 subjects with persistent isolated anti-HBc antibody who were HBsAg-negative received hepatitis B vaccination at 0, 1 and 2 months; protective level of anti-HBs antibody was developed in 70.6% of them. This evidence concerns the gene KRT88P and hepatitis B virus infection.